114 related articles for article (PubMed ID: 26983400)
1. SIK2 regulates fasting-induced PPARα activity and ketogenesis through p300.
Zhang ZN; Gong L; Lv S; Li J; Tai X; Cao W; Peng B; Qu S; Li W; Zhang C; Luan B
Sci Rep; 2016 Mar; 6():23317. PubMed ID: 26983400
[TBL] [Abstract][Full Text] [Related]
2. Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.
Shao M; Shan B; Liu Y; Deng Y; Yan C; Wu Y; Mao T; Qiu Y; Zhou Y; Jiang S; Jia W; Li J; Li J; Rui L; Yang L; Liu Y
Nat Commun; 2014 Mar; 5():3528. PubMed ID: 24670948
[TBL] [Abstract][Full Text] [Related]
3. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.
Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R
J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism.
von Meyenn F; Porstmann T; Gasser E; Selevsek N; Schmidt A; Aebersold R; Stoffel M
Cell Metab; 2013 Mar; 17(3):436-47. PubMed ID: 23416070
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing.
Sengupta S; Peterson TR; Laplante M; Oh S; Sabatini DM
Nature; 2010 Dec; 468(7327):1100-4. PubMed ID: 21179166
[TBL] [Abstract][Full Text] [Related]
6. Hepatic PPARα function is controlled by polyubiquitination and proteasome-mediated degradation through the coordinated actions of PAQR3 and HUWE1.
Zhao Z; Xu D; Wang Z; Wang L; Han R; Wang Z; Liao L; Chen Y
Hepatology; 2018 Jul; 68(1):289-303. PubMed ID: 29331071
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profiling of PPARα-/- and CREB3L3-/- livers reveals disparate regulation of hepatoproliferative and metabolic functions of PPARα.
Ruppert PMM; Park JG; Xu X; Hur KY; Lee AH; Kersten S
BMC Genomics; 2019 Mar; 20(1):199. PubMed ID: 30866796
[TBL] [Abstract][Full Text] [Related]
8. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.
Badman MK; Pissios P; Kennedy AR; Koukos G; Flier JS; Maratos-Flier E
Cell Metab; 2007 Jun; 5(6):426-37. PubMed ID: 17550778
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Hepatic PPARα Activity Links GLUT8 Deficiency to Augmented Peripheral Fasting Responses in Male Mice.
Mayer AL; Zhang Y; Feng EH; Higgins CB; Adenekan O; Pietka TA; Beatty WL; DeBosch BJ
Endocrinology; 2018 May; 159(5):2110-2126. PubMed ID: 29596655
[TBL] [Abstract][Full Text] [Related]
10. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.
Inagaki T; Dutchak P; Zhao G; Ding X; Gautron L; Parameswara V; Li Y; Goetz R; Mohammadi M; Esser V; Elmquist JK; Gerard RD; Burgess SC; Hammer RE; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2007 Jun; 5(6):415-25. PubMed ID: 17550777
[TBL] [Abstract][Full Text] [Related]
11. Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
McCarthy TC; Pollak PT; Hanniman EA; Sinal CJ
J Pharmacol Exp Ther; 2004 Dec; 311(3):864-73. PubMed ID: 15265979
[TBL] [Abstract][Full Text] [Related]
12. PAQR9 regulates hepatic ketogenesis and fatty acid oxidation during fasting by modulating protein stability of PPARα.
Lin Y; Chen L; You X; Li Z; Li C; Chen Y
Mol Metab; 2021 Nov; 53():101331. PubMed ID: 34474167
[TBL] [Abstract][Full Text] [Related]
13. CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα.
Nakagawa Y; Satoh A; Tezuka H; Han SI; Takei K; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Iwasaki Y; Sone H; Matsuzaka T; Yamada N; Shimano H
Sci Rep; 2016 Dec; 6():39182. PubMed ID: 27982131
[TBL] [Abstract][Full Text] [Related]
14. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism.
van Diepen JA; Jansen PA; Ballak DB; Hijmans A; Hooiveld GJ; Rommelaere S; Galland F; Naquet P; Rutjes FP; Mensink RP; Schrauwen P; Tack CJ; Netea MG; Kersten S; Schalkwijk J; Stienstra R
J Hepatol; 2014 Aug; 61(2):366-72. PubMed ID: 24751833
[TBL] [Abstract][Full Text] [Related]
15. Insights into the role of hepatocyte PPARα activity in response to fasting.
Régnier M; Polizzi A; Lippi Y; Fouché E; Michel G; Lukowicz C; Smati S; Marrot A; Lasserre F; Naylies C; Batut A; Viars F; Bertrand-Michel J; Postic C; Loiseau N; Wahli W; Guillou H; Montagner A
Mol Cell Endocrinol; 2018 Aug; 471():75-88. PubMed ID: 28774777
[TBL] [Abstract][Full Text] [Related]
16. Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.
Kim H; Mendez R; Chen X; Fang D; Zhang K
Mol Cell Biol; 2015 Dec; 35(24):4121-34. PubMed ID: 26438600
[TBL] [Abstract][Full Text] [Related]
17. SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes.
Du J; Chen Q; Takemori H; Xu H
Obesity (Silver Spring); 2008 Mar; 16(3):531-8. PubMed ID: 18239551
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
